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Nephrons scar and involute during aging, increasing the 
risk of chronic kidney disease. Little is known, however, 
about genetic mechanisms of kidney aging. We sought to 
define the signatures of age on the renal transcriptome 
using 563 human kidneys. The initial discovery analysis of 
260 kidney transcriptomes from the TRANScriptome of 
renal humAn TissuE Study (TRANSLATE) and the Cancer 
Genome Atlas identified 37 age-associated genes. For 19 of 
those genes, the association with age was replicated in 303 
kidney transcriptomes from the Nephroseq resource. 
Surveying 42 nonrenal tissues from the Genotype-Tissue 
Expression project revealed that, for approximately a fifth 
of the replicated genes, the association with age was 
kidney-specific. Seventy-three percent of the replicated 
genes were associated with functional or histological 
parameters of age-related decline in kidney health, 
including glomerular filtration rate, glomerulosclerosis, 
interstitial fibrosis, tubular atrophy, and arterial narrowing. 
Common genetic variants in four of the age-related genes, 
namely LYG1, PPP1R3C, LTF and TSPYL5, correlated with the 
trajectory of age-related changes in their renal expression. 
Integrative analysis of genomic, epigenomic, and 
transcriptomic information revealed that the observed age-
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related decline in renal TSPYLS expression was determined 
both genetically and epigenetically. Thus, this study 
revealed robust molecular signatures of the aging kidney 
and new regulatory mechanisms of age-related change in 
the kidney transcriptome. 
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A 
ging is associated with a decline in health and integrity of the human kidney. 1 Indeed, from the fourth decade of life, the glomerular filtration rate falls by 8 ml/min per 1.73 m2 every 10 years.2 Moreover, the kidney undergoes structural remodeling with age.3'4 Macroscopically, kidney mass and blood flow decline with age. 3•5 •6 These changes are likely to contribute to the known increase in risk of chronic kidney disease (CKD) with age. 7 Genetic mechanisms may impact renal aging, and previous gene expression profiling experiments highlighted molecules associated with the development of age-related changes in the kidney. 8•9 These studies had several caveats: they used small numbers of samples, typically fewer than 100; lacked robust replication in independent cohorts; and used microarrays to quantify the expression of genes in the kidney. In contrast to microarrays, next-generation RNA-sequencing (RNA-seq) allows for an unbiased hypothesis-free approach to 
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J Rowland et al.: Genes, aging, and the kidney transcriptome profiling and increased sens1t1V1ty to detect changes in genes with low levels of expression such as long noncoding RNAs.10'11 Thus, previous studies may not havedefined certain genes relevant to kidney aging because of limitations in technology or sample size, whereas the genes that were identified were not replicated in other populations. It also is unclear whether the expression of age-associated kidney genes is controlled, at least in part, by genetically and/or epigenetically inherited variations in DNA Single differences in DNA sequences determine phenotypic variation in health and disease, for example, through differential effects on gene expres­sion.12' 13 Several recent studies have reported associations be­tween common single-nucleotide polymorphisms (SNPs) and human aging,14 as well as renal gene expression.15 Epigeneticmodifications, such as DNA methylation, also can modify gene expression.16 Indeed, aging is accompanied by genome-widehypomethylation and site-specific hypermethylation, at least in nonrenal tissues. 17 The age-related changes in regional 5'-C­phosphate-G-3' site (CpG) methylation across tissues have been used to derive a global epigenetic signature as a measure of biological age.18·19 Nevertheless, patterns of DNA methylation arehighly variable across different tissues and a majority of methyl­ation studies have been conducted on tissues other than the kidney.20In this study, we identified robust signatures of age on the renal transcriptome by studying a large assembly of human kidneys characterized by RNA-seq. We identified several genes that showed similar age-related changes across different human tissues, while others represented kidney-specific aging signatures. We also found associations between these signatures and certain functional and structural measures of kidney health. Finally, by integrating genomic, epigenomic, and transcriptomic informa­tion, we uncovered new regulatory mechanisms underlying the expression of age-related signatures in the human kidney. 
RESULTS 
Signatures of age on kidney transcriptome: discovery analysis The design and delivery of the project is shown in the flow chart in Figure 1. In total, 160 patients from the TRANScriptome of renaL humAn TissuE (TRANSLATE) Study and 100 individuals from The Cancer Genome Atlas (TCGA) were included in the discovery analysis. The clinical characteristics of both studies are shown in Table 1. A total of 15,791 kidney genes common to both data sets were included in the analysis. After correction for multiple testing, 37 genes were associated with age (Figure 2, Supplementary Figure Sl, and Supplementary Table Sl). Of these, 33 were protein-coding and 4 were long noncoding RNAs. Biological characteristics of these genes are shown in Supplementary Table S2. Only 1 gene, EGF, overlapped with 307 genes implicated in aging from the GenAge database.21 Taking advantage of clinical information available in the TRANSLATE Study, we further examined the potential effects of common cofounders or comorbidities on tl1e association between age and renal gene expression. The sensitivity analysis showed that after adjusting for body mass index, hypertension, and diabetes mellitus, 30 of the 37 genes (81 %) retained associations with age 
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clinical investigation in the TRANSLATE Study at the nominal level of statistical sig­nificance of 5% (Supplementary Table S3). 
Signatures of age on kidney transcriptome: replication 
analysis We identified a total of 303 glomerular/renal cortex transcriptomes and 299 tubulointerstitial/renal medulla tran­scriptomes from eligible studies in Nephroseq.22 Of 37 age­associated genes, 32 were available for replication. Separate meta-analyses of renal cortex and medulla showed 12 and 18 associations with age, respectively, after correction for multiple testing (Supplementary Tables S4 and S5). A total of 19 kidney genes (59.3% of those available for this analysis) associated with age in the discovery analysis replicated in the same direction of association in Nephroseq (Figure 2). Additional sensitivity anal­ysis showed that most ( 60%) of the age-associated genes that replicated exclusively in apparently healthy kidney tissues8 overlapped with those identified in the replication limited to samples from patients with kidney disease.23·24 
Ubiquitous and kidney-specific gene signatures of aging Three (16%) of the replicated genes, EGF, EDH3, and LYGl, showed enriched kidney RNA/protein expression in the Human Protein Atlas25 (Supplementary Table S2). Although most of the age-associated kidney genes were abundant in other tissues, we reasoned that age-related changes in expression of these genes may be different compared with nonrenal tissues. To identify genes correlating with age exclusively in the kidney, we first conducted an association analysis between age and gene expression in 42 nonrenal Genotype-Tissue Expression (GTEx) project tissues from 532 individuals. The overview of the tissues included in this analysis and the demographic characteristics of the GTEx subjects are shown in Supplementary Tables S6 and S7. This analysis showed between O and 276 associations of age with gene expression in different tissues (Supplementary Table S6). All of our 19 replicated kidney genes were available for an overlap analysis with the transcriptomic signatures of age in the GTEx project (Supplementary Table S8). Under the initially selected statistical criteria, 15 (79%) of these showed no overlap with age-associated GTEx genes in this analysis (Figure 2 and Supplementary Table S8). Further sensitivity analyses were conducted under several alternative scenarios, with a different number of probabilistic estimations of expression residuals­derived factors in the nonrenal GTEx tissues. These showed that only 5 genes, comprising 26% of the replicated genes, showed no association with age in any of the statistical scenarios in any nonrenal tissues (Supplementary Table S9). As such, these genes, EDH3, ERP27, MAP4, PPP1R3C, and SNX24, represent tissue-specific signatures of age on the kidney transcriptome. 
Robust gene signatures of kidney aging and their correlation 
with functional and structural dimensions of kidney health Of 19 replicated genes, 14 showed at least 1 nominally significant association with 1 of 5 biochemical or histologic measures of renal functional and structural integrity known to deteriorate with age (i.e., estimated glomerular filtration rate, 
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Figure 1I Illustration of key stages of the project together with the main outcomes. TCGA, The Cancer Genome Atlas; TRANSLATE Study, 
TRANScriptome of renal humAn TissuE Study; Nephroseq renal cortex, a combination of 3 separate studies of renal cortex/glomerulus from 
Nephroseq resource; Nephroseq renal medulla, a combination of 3 separate studies of renal medulla/tubulointerstitium from Nephroseq resource; 
GTEx, Genotype-Tissue Expression project; cis-eQTL, cis-expression quantitative trait locus; cis-mQTL, cis-methylation quantitative trait locus; 
eGene, gene whose renal expression is associated with at least 1 single-nucleotide polymorphism in-cis after correction for multiple testing; 
mSNP, gene whose renal DNA methylation is associated with at least 1 single-nucleotide polymorphism in-cis after correction for multiple 
testing; CPG, 5'-C-phosphate-G-3' site; eSNP, transcriptionally active single-nucleotide polymorphism. glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arterial/arteriolar narrowing) in up to 160 individuals from the TRANSLATE Study (Supplementary Tables Sl0-Sl4, Figure 2, and Supplementary Figure S2). The direction of these asso­ciations was always consistent with the expected age-related decline in kidney health. After correction for multiple testing, 10 genes retained their statistically significant associ­ations with at least 1 measure of kidney health (Supplementary Tables Sl0-Sl4 and Supplementary Figure S2), as follows: ATP1B2, EGF, EHD3, MAP4, SLPI, TMEM54, SLC16A5, ZNF518B, TRIM26, and TSPYL5. Sta­tistically, the most significant relationship was detected be­tween decreasing kidney expression of TSPYL5 and increasing 
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arterial/arteriolar narrowing (P = 6.3 x 10-5, false discovery rate, 0.0015) (Supplementary Table Sl4). Further sensitivity analyses showed that age adjustment reduced or completely abolished the statistical significance of all genes (Supplementary Tables Sl0-Sl4), consistent with a key role of aging in the uncovered associations between renal gene expression and indices of kidney health. 
Cross-species validation of age-related human kidney genes 
in rodents Of 19 genes showing association with human age at the renal expression level, 8 had murine homologs (Egf, Ltf, Lygl, Phlda3, Slc16a5, Slpi, Snx24, and Vim) profiled on the gene 
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Table 1 I Demographic and selected clinical characteristics of 
the TRANSLATE Study and TCGA 
Characteristics TRANSLATE Study TCGA 
N 160 100 
Age, yr 63.2 ± 10.4 61.4 ± 13.3 
Age range, yr 30-87 28-86
Male sex 99 (62%) 69 (69%) 
White-European ethnicity 160 (100%) 100 (100%) 
Body mass index, kg/m2 28.2 ± 5.2 
Hypertension 116 (73%)
Diabetes 29 (18%)
eGFR, ml/min per 1.73 m2 75.3 ± 19.1
Glomerular sclerosis 59/82/13/0
Interstitial fibrosis 70/70/14/0
Tubular atrophy 67/69/17/1
Arterial/arteriolar narrowing 15/94/39/6
eGFR, estimated glomerular filtration rate; TCGA, The Cancer Genome Atlas; 
TRANSLATE, TRANScriptome of renal humAn TissuE Study. 
Data are counts (and percentages where appropriate), means and SDs or ranges. For 
histologic phenotypes (n = 154), data are numbers with Remuzzi's scale from Oto 3 
(0/1 /2/3), where O indicates none to minimal damage and 3 indicates maximal 
damage. expression microarray/available for in silica replication.26 The renal expression of 4 of these genes (Egf, Phlda3, Slpi, and Vim) showed a statistically significant association with murine age, at least at the nominal level of statistical significance (Supplementary Table Sl5). Phlda3, Slpi, and Vim also were associated with the histologic measure of age-related decline in kidney health, namely glomerular membrane thickening and tubular degeneration, in mice (Supplementary Table Sl5). In the absence of availability of TSPYL5 for vali­dation in mice, we measured age-related changes in the expression of this gene in rat kidneys.27 This analysis showed reduced renal expression of TSPYL5 with age (Supplementary Figure S3). Collectively, these studies show a high level, approximately 50%, of cross-species replication of age-related kidney genes between man and rodents. 
lmmunohistochemistry of TSPYLS in human kidneys In kidneys from 9 TRANSLATE Study individuals, immu­nostaining for TSPYL5 detected a common pattern of signals in tubules, in a cytoplasmic location, with 2 representative samples shown in Figure 3. Further quantitative analysis of TSPYL5 immunostaining showed numerically lower signal intensity in kidneys from older individuals (age, >60 yr) when compared with those younger than 60 years, but the difference was not statistically significant (P = 0.176) (Supplementary Figure S4). 
Genetic regulation of renal expression of age-associated 
genes To determine the extent of genotype-dependent variation in the expression of the 19 age-associated genes, we performed in-cis meta-expression quantitative trait locus analysis of the TRANSLATE Study and TCGA data with a window of 1 Mb. After correction for multiple testing, 4 (21 % ) genes, LTF, LYGl, PPP1R3C, and TSPYL5, showed significant correlations with 797 variants in-cis (Table 2 and Supplementary 
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clinical investigation Tables Sl6 and Sl 7). All most significant variants (best transcriptionally active single-nucleotide variants-best eSNPs) mapped to noncoding regions of the genome; 3 of them within actively transcribed chromatin regions in adult kidney tissue (Supplementary Table Sl8). Genotypes of the best eSNPs showed fairly constant effects on the age-related changes in renal gene expression (Supplementary Figure S5). We further examined associations between the genotypes of 797 PPP1R3C, TSPYL5, LYGl, and LTF eSNPs and estimated the glomerular filtration rate in 110,527 in­dividuals from the CKDGen Consortium.28 Of 723 variants available for analysis, 105, 55, and 4 eSNPs in PPP1R3C, TSPYL5, and LYGl, respectively, showed an association with estimated glomerular filtration rate in the CKDGen Con­sortium, at least at the nominal level of statistical significance (Supplementary Table Sl9). The best eSNPs of PPP1R3C (rs7077656) and TSPYL5 (rs2567772) were among the eSNPs associated with an estimated glomerular filtration rate in the CKDGen Consortium. Thus, many genetic variants that control expression changes of kidney aging genes also are associated with a surrogate of kidney function. 
DNA methylation of age-associated genes and their 
expression To investigate possible effects of DNA methylation on gene expression, we examined whether differences in CpG methylation of kidney DNA in proximity to 19 age-associated genes correlate with their renal expression in 78 TRANSLATE Study individuals. We examined the extent of DNA methyl­ation in all CpG sites mapping to 1000 base pairs from either side of the age-associated gene. After correction for multiple testing, methylation of 1 gene, TSPYL5, showed an inverse association with its renal expression; the strongest association was identified for cg22328208 probe mapping to the TSPYL5 promoter (P = 2.3 x 10-4, Permutation P [Ppenn l = 1 x 10-3, false discovery rate, 0.019) (Table 3, Supplementary Table S20, and Figure 4). We further confirmed that methylation of the TSPYL5 promoter was associated with a reduction in its expression using data generated in in vitro experiments (Supplementary Table S21). 
Association between age, renal methylation, and expression 
of TSPYLSWe detected the association between age and 3 CpG probes associated with the expression of TSPYL5 in 93 TRANSLATE Study individuals (Supplementary Table S22). The positive association of cg22328208 methylation with age is in agree­ment with the demonstrated negative association between renal expression of TSPYL5 and a decrease in the kidney abundance of TSPYL5 with age (Table 3, Supplementary Table S22, and Figure 4). We then confirmed the associa­tion between cg22328208 methylation and age in an inde­pendent collection of 126 kidney samples from TCGA (Supplementary Table S23). Further mediation analysis in the TRANSLATE Study showed that the effect of age on 
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Figure 21 Overview of kidney genes associated with age. Chromosome numbers appear at the top of the circle and proceed clockwise. 
Track 1: The level of statistical significance (-log10 P values) from meta-analysis of association between renal gene expression and age in the 
TRANScriptome of renal humAn TissuE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA). Track 2: Symbols of 37 kidney genes 
associated with age in the meta-analysis of the TRANSLATE Study and TCGA after the correction for multiple testing. Track 3: Direction of 
association between expression of a gene and age (based on B-coefficients from the meta-analysis of the TRANSLATE Study and TCGA). Yellow, 
positive: gene is upregulated with increasing age; pink, negative: gene is downregulated with increasing age. Track 4: Prior evidence for as­
sociation with aging determined via search of PubMed, GenAge, and AgeMap databases. Blue, genes previously associated with age; orange, no 
previous association with age. Track 5: Kidney genes associated with age in Nephroseq resource (red). Track 6: Kidney-specific (in purple) and 
ubiquitous (in green) signatures of age (based on the analysis of nonrenal tissues). Tracks 7 to 11: Associations between replicated age-related 
kidney genes and estimated glomerular filtration rate (track 7), glomerulosclerosis (track 8), interstitial fibrosis (track 9), tubular atrophy (track 
10), and arterial/arteriolar narrowing (track 11 ). At least nominally significant associations are shown in blue. cg22328208 is primary to changes in TSPYL5 expression in the kidney (P = 0.0118) (Figure 4). Collectively, these data show that age-related increase in methylation of the TSPYL5 promoter in the kidney translates into a decrease in the renal expression of TSPYL5. 
Genotype-dependent effect on kidney DNA methylation of 
TSPYLS Genetic variation is known as one of the regulatory mecha­nisms for CpG methylation in human tissues. Therefore, we sought to identify common variants associated with methyl­ation of cg22328208 in 93 TRANSLATE Study individuals. This cis-methylation quantitative trait locus analysis used a window of 33,172 base pairs, the maximum distance between TSPYL5 and its eSNPs plus its own length, from the target CpG site and showed that after correction for multiple testing, cg22328208 was associated with 70 SNPs (Supplementary Table S24). The strongest association was identified for rsl367917 (Figure 4). These data confirmed that 
628 
interindividual differences in renal DNA methylation of TSPYL5 are dependent on genotype. 
Mediation analysis and causality between kidney methylation 
and expression of TSPYLSWe jointly investigated the identified cis-expression quanti­tative trait locus and cis-methylation quantitative trait locus of TSPYL5 in 93 TRANSLATE Study samples that had infor­mative eQTL and mQTL data: 62 of 65 eSNPs overlapped with the set of 70 single-nucleotide variants with effect on methylation (mSNPs) (Supplementary Table S25). The mediation analysis based on the set of overlapping SNPs, TSPYL5 methylation, and expression was consistent with the epigenetic mediation model: both the best mSNP (rsl367917; P = 1.07 x 10-6) and the best eSNP (rs2567772; P = 1.32 x10-3) were linked to TSPYL5 expression through cg22328208 methylation (Figure 4). Further Mendelian randomization using TSPYL5 SNPs as instruments, cg22328208 methylation as exposure, and TSPYL5 expression as outcome, and both 
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Figure 3 j lmmunohistochemistry of TSPYLS in human kidneys. (a,b,e,f) Sections were immunostained for TSPYLS (brown signal), (c,d) 
except where the primary antibody was omitted. All sections were counterstained with hematoxylin (blue nuclei). (a) Low-power overview of 
kidney cortex of a 58-year-old individual showing glomeruli and tubules. (b) High-power view of boxed area in panel a. Larger tubules (t) have 
prominent TSPYLS immunostaining, with a cytoplasmic pattern. Smaller tubules (arrows) in the fibrotic area (*) appear to have less prominent 
TSPYLS signals. (c,d) Negative controls in which goat anti-rabbit secondary antibody was applied but the primary antibody was omitted. 
(e) Low-power overview of kidney cortex of an 81-year-old individual showing prominent zones of atrophic tubules and fibrosis. (f) High-power
view from sample in panel e: in some tubules TSPYLS signals appear confined to a subset of cells (arrow). Bars = (a,c,e) 200 µm, and (b,d,f) 
50 �1m. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. inverse variance weighting and weighted median methods showed a causal effect of cg22328208 methylation on renal TSPYL5 expression; the effect estimates were -0.563 (95% confidence interval, -0.326 to -0.801) and -0.655 (95% con­fidence interval, -0.071 to -1.24) (Figure 4). The Mendelian randomization-Egger regression indicated that there was no pleiotropy of the instruments (P = 0.291). 
Functional analysis of TSPYLS locus in silico We used Roadmap Epigenomics chromatin immunopre­cipitation sequencing data for 4 key histone modifications to determine chromatin state segmentation in an adult kidney and overlapped chromatin states and chromatin immunoprecipitation-sequencing signal intensity across the TSPYL5 locus (Supplementary Figure S6). The cg22328208 CpG site overlapped with the transcription 
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start site of the TSPYL5 gene and is in a transcription start site chromatin region ( l_ TssA) in adult kidney tissue. 29 It is part of a CpG island. Histone modification intensity in the region showed a strong enrichment for H3K4me3 (a mark of high specificity to promoter regions). The best eSNP (rs2567772) and mSNP (rsl367917) are 9.1 kb and 23.5 kb downstream from TSPYL5 and map to a weakly transcribed chromatin state (5_TxWk) and quiescent chromatin (15_Quies) in adult human kidney, respectively (Supplementary Table S26). Integrative analysis of high­resolution (5-10 kb) genome-wide high throughput chromosome confirmation capture chromatin interaction data30 showed statistically significant physical interactions between regions proximal to the mSNP and eSNP ( or their proxies) and the promoter region of TSPYL5 (Supplementary Figure S6 and Supplementary Table S27). 
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Table 2 I Association between age-related kidney genes and their best eSNPs: cis-expression quantitative locus meta-analysis 
of the TRANSLATE Study and TCGA 
Distance from gene to SNP, Permutation 
Chr Gene symbol rslD base pairs Alleles � SE P value P value FDR 
10 PPPIR3C rs7077656 -18,450 A/G -0.428 0.062 5.44E-12 5.00E-04 1.64E-03 
8 TSPYLS rs2567772 -4622 G/A 0.287 0.043 1.58E-11 5.00E-04 1.64E-03 
3 LTF rs6763280 0 G/A 0.283 0.043 4.48E-11 5.00E-04 1.64E-03 
2 LYGI rs6734290 20,339 G/f -0.244 0.040 1.46E-09 5.00E-04 1.64E-03 
Alleles, reference/alternate allele; B, coefficient from linear regression models; Chr, chromosome; FDR, false discovery rate; permutation P value, P value obtained based on 
2000 permutations; rslD, reference SNP ID; SNP, single-nucleotide polymorphism. 
DISCUSSION Our study provides several insights into age-related gene expression changes within the kidney. First, we identify genes whose expression not only robustly correlates with age in independent data sets but also is associated with biochemical/ histologic measures of age-related changes in renal health. Second, we provide evidence for the key role of common genetic variants as determinants of lifelong, age-related changes in the renal signatures of aging. Finally, through integration of information from the genome, epigenome, and transcriptome we identify TSPYL5 as a robust gene whose age-related change in kidney expression is mediated through genetically determined hypermethylation of its promoter. Only 6 (31.6%) (EGF, LTF, SLPI, SLC16A5, VIM, and TSPYL5) of 19 robust signatures of age-related changes in kidney transcriptome were linked to human aging or age­related kidney diseases in previous studies. For example, EGF expression is known to correlate inversely with CKD, renal fibrosis, and rapidly progressive glomerulonephritis. 23•31 Changes in renal expression of 2 other genes (LTF and SLPI) were linked to acute kidney injury. 32'33 LTF is an antibacterial,anti-inflammatory, and antioxidant factor providing an innate line of defense against a host of injury stimuli.34 SLPIprotects epithelial cells from the effects of inflammation and the activity of endogenous proteolytic enzymes.35•36 To thisend, the identified increase in the expression of LTF and SLPl with age may represent a kidney repair mechanism in response to activation of aging-related processes in that organ. The degree of overlap between age-related genes and those that constitute the transcriptomic signatures of kidney injury identified before suggests the existence of a commonality in transcriptional pathways of renal damage repair irrespective of the initial insult. Our data link a majority of the replicated age-associated kidney genes to the functional and structural parameters of renal health known to deteriorate with age. Indeed, the 
Table 3 I Associations between TSPYLS CpG methylation, 
TSYLS renal expression, and chronological age in the 
TRANSLATE Study 
Chr CpG probe Trait � SE FDR 
8 cg22328208 TSPYLS expression -0.545 0.135 0.019 
Age 0.016 0.004 <0.001 
B, coefficient from linear regression models; Chr, chromosome; CpG probe, DNA 
methylation probe; FDR, false discovery rate. 
630 
age-related decline in glomerular filtration rate affects up to 57% to 85% of individuals in the general population.37-39 Glomerular sclerosis, interstitial fibrosis, tubular atrophy, and arterial narrowing represent the age-related changes in the structural microarchitecture of the kidney. 39 Theirgradual progression inevitably leads to a loss of functional nephron reserve and atrophy, increasing the susceptibility of elderly patients to severe presentations of CKD and other renal disorders.3 The associations between these phenotypes and our age-related genes suggest that a majority of the uncovered signatures are not silent bystanders but more likely are contributors to the key processes underpinning a gradual functional and structural involution of renal tissue with aging. We also show a powerful effect of the inherited variation in DNA sequence on the kidney expression of genes related to ag­ing. Our data suggest that for approximately 1 in 5 renal genes robustly associated with age, common variants mapping to their proximity determine the lifelong pattern of their expression in the kidney. This means that the pace with which kidneys age is determined at least in part at birth and those who inherited a genotype promoting steeper expression changes of aging signa­tures may be at higher risk of age-related decline in kidney health (given the demonstrated overlap between age-related changes in renal gene expression and markers of functional and structural kidney damage). Thus, prediction of the magnitude of age­related changes in transcriptome based on genotype could lead to the development of new important diagnostic avenues. Indeed, noninvasive genotyping of faster renal aging risk variants might be an attractive strategy for early screening of age-related kidney diseases and suitability of organ donation in kidney transplantation.4 One of tl1e most interesting genes uncovered by our study is TSPYL5, a member of the nucleosome assembly protein superfamily known for their role in transcriptional regulation and cell cycle.40 TSPYL5 was implicated in the processes operating at the intersection of cellular senescence and carcinogenesis.40 Specifical y, TSPYL5 was suggested to. 3 . d th . . f 1 41 42 rmpact on pS expression an e acttVIty o te omerase, · and was predicted to associate with telomere length.43 Therecent in vitro TSPYLS knockdown experiments in human pluripotent stem cells showed that silencing of this gene leads to changes in the expression of numerous pathways, including those responsible for changes in DNA conformation, epige­netics, and telomere organization.44 These processes map
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Figure 41 TSPYLS: associations between renal expression, methylation, age, and genotype. (a) Association between kidney expression of 
TSPYLS and age in the meta-analysis of the TRANScriptome of renal humAn TissuE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA) 
study. Meta P value, level of statistical significance from the joint analysis; meta false discovery rate (FDR), the level of statistical significance 
after the correction for multiple testing. (b) Association between kidney expression of TSPYLS and its best eSNP (rs2S6772) in the meta-analysis 
of TRANSLATE and TCGA studies. Meta P value, level of statistical significance from the meta-analysis; meta FDR, the level of statistical sig­
nificance after the correction for multiple testing. (c) Trajectories of age-related reduction in kidney expression of TSPYLS stratified on the 
genotype of rs256772 in the combined TRANSLATE and TCGA studies. (d) Association between kidney expression of TSPYLS and the extent of 
renal DNA methylation within the cg22328208 probe in the TRANSLATE Study. P value, nominal level of statistical significance; FDR, the level of 
statistical significance after correction for multiple testing. (e) Association between the extent of renal DNA methylation within the cg22328208 
probe and age in the TRANSLATE Study. P value, level of statistical significance. (f) Association between the extent of renal DNA methylation 
within the cg22328208 probe and its best single-nucleotide variant with effect on methylation (mSNP) (rsl 367917). P value, nominal level of 
statistical significance. (g) Effect of age on the kidney expression of TSPYLS is mediated through the extent of renal DNA methylation 
within cg22328208 in the TRANSLATE Study. (h) Effects of the best eSNP (rs256772) and the best mSNP (rsl 367917) on the renal expression of 
TSPYLS are mediated through the extent of renal DNA methylation within cg22328208 in the TRANSLATE Study. (i) The causal effect of 
methylation at cg22328208 on kidney expression of TSPYLS using 6 independent genetic instruments (transcriptionally active single-nucleotide 
polymorphisms [SNPs]) in Mendelian randomization by inverse variance weighting (orange line) and weighted median (blue line). The green 
dots with arrow bars represent genetic associations with kidney expression of TSPYLS against genetic associations with cg22328208 methyl­
ation (with 95% confidence intervals). RBINT, rank-based inverse normal transformation. onto the basic molecular and cellular underpinnings of aging including regulation of chromatin architecture, epigenetic control of transcription, and cellular senescence.45 Our results show that an age-related decrease in the renal expression of TSPYL5 is most likely mediated directly by CpG methylation, with the strongest signal mapping to the 5' region of the gene. Jung et al. 46 determined that this segmentof TSPYL5 including exon 1 contains the transcription start site and lies within a CpG island. This was supported by our analysis in silica. The association between the methylation and expression of TSPYL5 has been reported previously in other human tissues including both apparently healthy and diseased tissues.47•48 The methylation of TSPYL5 also was associated
Kidney International (2019) 95, 624-635 
with other age-related conditions including Huntington's disease.49 Notably, the degree of hypermethylation of TSPYL5promoter in the kidney remains under genetic control and is linked causally to the renal expression of this gene, but the strongest mSNP is located more than 20,000 base pairs from the TSPYL5 promoter. Similar intronic/intergenic SNPs distant to the methylated CpG sites were shown as the reg­ulators of their methylation in previous studies.47 Our in silicastudies further suggest that long-range chromatin interactions between the chromatin segments overlapping with the TSPYL5 promoter and the distant regions where the best mSNP maps are plausible explanations for the detected associations. 
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clinical investigation Certainly, there were limitations of our analyses. The noncancerous renal tissues analyzed in both the TRANSLATE and TCGA cohorts were sourced from nephrectomies per­formed for primary kidney cancers. However, our previous investigations showed that the presence of cancer does not affect the transcriptome of kidney tissue collected from the cancer-unaffected part of the kidney.50 Moreover, the tissues within the replication resource that validated the associations between 19 renal genes and age came mostly from noncancer patients. Thus, it is unlikely that the history of renal cancer in the donors had a confoW1ding effect on our results. We also appreciate the limited size of our kidney methylation data set in the TRANSLATE Study. The power limitation was the most likely reason why Olli study uncovered only 1 independent association between age-related gene expression and methyl­ation after the stringent correction for multiple testing. However, 63% of our renal signatures showed nominally significant associations with kidney DNA methylation (Supplementary Table S20) and/or were correlated with CpG methylation in other human tissues.47'51 Finally, weacknowledge the limitations of the quantitative analysis of TSPYLS immunostaining restricted to 9 human kidneys. These samples represent only a small fraction of the set of renal tissues from more than 500 individuals examined at the transcriptome level. Thus, the arising results likely were w1-derpowered for defining changes in the target protein with age. In the future, the complete spectrum of protein changes will need to be measured in several hundreds of samples using high-throughput proteomic approaches. Despite these caveats, our analysis linked age-related changes in kidney expression to genome and epigenome and show compelling evidence for promoter hypermethylation as the causal mechanism for an age-related decrease in renal expression of one of the uncovered signatures. We stress that our discovery analysis was based exclusively on RNA-seq, the state-of-the-art method of RNA profiling to measure transcript abundance. We also applied stringent statistical methods in the analyses of association between gene signatures and aging. Previous studies relying on much smaller numbers of kidney samples, collected largely in a similar manner to the TRANSLATE Study and TCGA but profiled using microarrays, used less-stringent statistical thresholds and lacked an independent replication. Therefore, it is not possible to exclude the role of a type 1 error in relation to approximately 1000 reported associations with age in these investigations.8 Most notably, the magnitude of dis­covery for age-associated kidney genes in our analysis is consistent with that for a majority of nonrenal GTEx tissues processed by RNA-seq and examined using similar statistical pipelines. Therefore, we are confident that the identified genes represent robust signatures of age on kidney transcriptome. In summary, with 260 kidneys exanlined at the discovery stage and more ilian 300 kidneys analyzed in the replication phase, Olli study was a large analysis of changes in ilie hW11an renal tran­scriptome in relation to aging. We W1covered new robust gene signatures of kidney aging, showed ilieir relevance to age-related 
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J Rowland et al.: Genes, aging, and the kidney decline in renal healili, and demonstrated ilie potential of inte­grative -omics to W1cover new regulatory mechanisms W1der­pinning age-related changes in renal gene expression. 
METHODS 
Discovery analysis of association between gene expression and 
chronological age was conducted using data from 2 projects: the 
TRANSLATE Study5° ·52 and TCGA.53 First, separate analyses were 
performed on the 2 data sets, then the results were combined 
using an inverse-variance method. Kidney transcriptome profiling 
in both projects was conducted by RNA-seq. Replication analysis 
was conducted using data from Nephroseq, a platform of 
comprehensive renal disease gene expression data sets.22 Within 
Nephroseq, we performed an analysis of age-associated genes using 
a collection of apparently healthy renal tissue from Rodwell et al.,8 
and 2 data sets based on specimens from patients with kidney 
disease by Ju et al. 23 and Sampson et al.,24 separately in kidney 
cortex and medulla. The number of age-associated genes in 42 
nonrenal tissues and the kidney specificity of replicated genes was 
examined using the data from the GTEx project.54•55 Replicated 
genes were examined further for association with renal function 
and structure, age-related renal changes in rodents and cell lines, 
common genotypes (expression quantitative trait locus analysis), 
associations with CKD, and kidney DNA methylation. Kidney 
tissues immunostaining was performed using 2 antibodies raised 
against TSPYL5. Each antibody provided similar patterns on 
kidney cortex sections from 9 TRANSLATE Study individuals, 
spanning an age range of 30 to 81 years. The relevant DNA 
methylation sites were examined for association with chronolog­
ical age and genotype (methylation quantitative trait locus 
analysis). 
Gene expression was quantified in transcripts per million and 
normalized using logarithmic transformation, quantile normali­
zation, and rank-based inverse normal transformation in both the 
TRANSLATE Study and TCGA. The extent of technical variation 
in the normalized gene expression data was determined using the 
probabilistic estimation of the expression residual method.56 All 
association analyses were conducted using multiple linear 
regression controlling for sex, the top 3 genotype principal 
components, and technical factors if appropriate. The statistical 
significance was determined based on the false discovery rate 
either using the Benjamini-Hochberg method or the method of 
Storey et al.57'58 We performed causal inference and mediation 
analysis and Mendelian randomization to explore the causal 
drivers of changes in gene expression. Bioinformatic analyses 
consisted of regulatory characterization of age-associated genes 
(Roadmap Epigenomics chromatin state), examining their organ 
specificity (Human Protein Atlas25 ) and long-range chromatin 
interactions (high throughput chromosome confirmation capture 
data59). Further details regarding the methods are provided in the 
Supplementary Data. 
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SUPPLEMENTARY MATERIAL 
Supplementary Data. 
Figure S 1. Analysis of association between age and kidney gene 
expression, a meta-analysis of the TRANScriptome of renal humAn Tis­
suE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA). �, a co­
efficient of regression from the meta-analysis, is plotted on the X axis, 
statistical significance [-log10 (P value)] is plotted on the Y axis (inversely 
log-transformed for ease of interpretation), the dotted line shows a 
threshold for correction for multiple testing [false discovery rate (FDR), 
5%], genes upregulated with age at FDR <0.05 are shown in green, genes 
down-regulated with age at FDR < 0.05 are shown in red. 
Figure S2. Analysis of association between replicated age-associated 
genes and 5 measures of renal health in the TRANScriptome of renal 
humAn TissuE (TRANSLATE) Study. Different colors show the magnitude 
of statistical significance for association between the expression of each 
individual gene and a given phenotype. Row 1: Genes whose expression 
increased with age in the TRANSLATE Study/The Cancer Genome Atlas 
(TCGA) analysis are shown in dark green. Genes whose expression 
decreased with age in the TRANSLATE Study/TCGA analysis are shown in 
red. Rows 2 to 6: Genes whose expression is associated positively with the 
given renal phenotype after correction for multiple testing [false dis­
covery rate (FDR), < 5%] are shown in dark green. Genes whose 
expression is associated positively with the given renal phenotype at the 
nominal level (P < 5%) are shown in light green. Genes whose expression 
is associated inversely with the given renal phenotype after correction for 
multiple testing (FDR, <5%) are shown in red. Genes whose expression is 
associated inversely with the given renal phenotype at the nominal level 
(P < 5%) are shown in orange. Genes whose expression was not asso­
ciated significantly with the given renal phenotype are shown in gray. 
The estimated glomerular filtration rate (eGFR) was calculated based on 
the EPI-CKD formula. 
Figure S3. Association of renal expression of TSPYLS with age in rats. 
P value: level of statistical significance from analysis of variance 
(ANOVA). 
Figure S4. Analysis of the difference in immunohistochemistry-derived 
signal intensity for kidney TSPYLS between younger (age, :560 yr) and 
older (age, >60 yr) individuals from the TRANScriptome of renal humAn 
TissuE (TRANSLATE) Study. N, number of individuals; P value, level of 
statistical significance using the Mann-Whitney U test. 
Figure S5. Associations between age, renal expression of signature 
genes, and their best eSNPs in the TRANScriptome of renal humAn 
TissuE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA). (A) 
Associations between the renal expression of each gene and age in 
the meta-analysis of the TRANS LA TE Study and TCGA. Meta P value, 
level of statistical significance from the meta-analysis of both studies; 
meta false discovery rate (FDR), the level of statistical significance 
after correction for multiple testing. (B) Renal expression of each gene 
stratified on the genotype of the best eSNP in the meta-analysis of 
the TRANSLATE Study and TCGA. meta P value, level of statistical 
significance from the meta-analysis of both studies; meta FDR, the 
level of statistical significance after correction for multiple testing. (C) 
Trajectories of age-related changes in renal expression of the 4 genes 
stratified on the genotype of the best respective eSNP in the meta­
analysis of the TRANSLATE Study and TCGA. 
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Figure S6. TSPYLS functional annotation to the locus on 
chromosome 8. Hi-C chromatin interactions are shown as gray 
arcs, the intensity of gray is determined by the number of times 
the interaction was observed. The best mSNP and eSNP are shown 
as large points in blue and yellow, respectively. mSNP and eSNP 
statistical proxies (r2 > 0.8 in 1000 Genomes European individuals) 
are shown as smaller points in blue and yellow, respectively. The 
CpG site (cg22328208) is shown in dark purple and its parent CpG 
island (chromosome 8: 98289605-98290404; 25% CpG content) is 
shown in light purple. The TSPYLS gene is shown as a gray region, 
with the coding exon black. Chromatin state information from 
adult kidney tissue is shown below the gene, red denotes tran­
scription start site regions, yellow indicates enhancer regions, and 
green indicates transcribed regions. Input histone modification 
chromatin immunoprecipitation (ChlP)-seq data signal is shown at 
the bottom; H3K4me3 is shown in red, H3K4me1 is shown in 
yellow, and H3K36me3 in green. The histone modification signal is 
calculated as the Loess smoothed density of ChlP-seq reads across 
the region, colors are from Roadmap Epigenomics. 
Table S1. Meta-analysis of association between renal genes and age 
in the TRANSLATE Study and TCGA. 
Table S2. Functional characterization of genes associated with kidney 
aging in the TRANSLATE Study and TCGA. 
Table S3. Effect of adjustment for comorbidities (body mass index, 
hypertension, and diabetes) on association between age and renal 
expression of 37 genes from the discovery analysis-sensitivity analysis in 
the TRANSLATE Study. 
Table S4. Replication of associations between renal genes and age in 
the renal cortex/glomerular compartment: meta-analysis of 3 sepa­
rate studies from Nephroseq resource. 
Table S5. Replication of associations between renal genes and age in 
the renal medulla/tubulointerstitial compartment: meta-analysis of 3 
separate studies from Nephroseq resource. 
Table S6. GTEx tissues included in the analysis of association 
between age and gene expression. 
Table S7. Demographic characteristics of individuals from GTEx. 
Table S8. Analysis of association between age and expression of age­
related renal genes in nonrenal GTEx tissues. 
Table S9. Sensitivity analyses of association between age and 
expression of age-related renal genes in nonrenal GTEx tissues. 
Table S10. Analysis of association between 19 robust age-related 
genes and estimated glomerular filtration rate in the TRANSLATE 
Study. 
Table S11. Analysis of association between 19 robust age-related 
genes and glomerular sclerosis in the TRANSLATE Study. 
Table S12. Analysis of association between 19 robust age-related 
genes and interstitial fibrosis in the TRANSLATE Study. 
Table S13. Analysis of association between 19 robust age-related 
genes and tubular atrophy in the TRANSLATE Study. 
Table S14. Analysis of association between 19 robust age-related 
genes and arterial/arteriolar narrowing in the TRANSLATE Study. 
Table S 15. Cross-species validation of 19 genes showing age-related 
changes in kidney expression: analysis of murine model of renal 
aging. 
Table S16. Gene signatures of kidney aging and their best eSNPs: 
meta analysis of the TRANSLATE Study and TCGA. 
Table S17. Gene signatures of kidney aging and their eSNPs: meta­
analysis of the TRANSLATE Study and TCGA. 
Table S18. Functional annotations of the 4 best eSNPs associated 
with renal expression of age-related gene signatures. 
Table S19. Association of eSNPs (for PPP1R3C, TSPYL5, LYG1, and 
LTF) with estimated glomerular filtration rate in CKDGen genome­
wide association study. 
Table S20. CpG sites associated with renal expression of age-related 
genes in the TRANSLATE Study. 
Table S21. The effect of TSPYLS methylation on its expression: cell 
lines. 
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Table S22. Association between methylation and age for 3 probes 
associated with renal expression of TSPYLS in the TRANSLATE Study. 
Table S23. Analysis of association between age and the extent of 
kidney DNA methylation at the TSPYLS promoter: replication in TCGA 
study. 
Table S24. Association between age- and gene-expression-related 
CpG sites and genetic variants in-cis: all significant mSNPs from mQTL 
analysis in the TRANSLATE Study (eQTL best eSNP is highlighted). 
Table S25. Overlap between mSNPs and eSNPs for TSPYLS.
Table S26. Functional annotation of the best mSNP for cg22328208 
in the TRANSLATE Study. 
Table S27. Chromatin interaction data from the 4DGenome database 
used in Figure S6. 
Table S28. Postimputation quality control for eQTL analysis in the 
TRANSLATE Study and TCGA. 
Table S29. Postimputation quality control for mQTL analysis in the 
TRANSLATE Study. 
Supplementary material is linked to the online version of the paper at 
www.kidney-international.org. 
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